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OBJECTIVES The aim of this retrospective study was to determine the predictors of diffuse in-stent
restenosis (ISR) among the lesions causing the first ISR by intravascular ultrasound (IVUS)
studies.
BACKGROUND Although some predictors of diffuse ISR have been reported, parameters on IVUS relating to
diffuse ISR are not well characterized.
METHODS We classified 52 ISR lesions that had undergone successful stent implantation and led to
restenosis into two types—focal and diffuse ISR—using quantitative coronary angiography.
Restenosis was defined as 50% diameter stenosis, and diffuse ISR as lesion length 10 mm
at follow-up. The remodeling index (RI) was defined as the vessel area at the target lesion
divided by that of averaged reference segments.
RESULTS There were no significant differences in patient, angiographic, and procedural characteristics
between the focal (n  25) and diffuse (n  27) ISR groups. Baseline RI was significantly
greater in the diffuse ISR group (1.03  0.18 vs. 0.88  0.24, p  0.0159). Negative
remodeling, defined as RI 0.9, was detected in 60% of the focal ISR group and in only 26%
of the diffuse ISR group. By logistic regression analysis, baseline RI was the only independent
predictor of diffuse ISR (p  0.0341). Moreover, volumetric analyses revealed that lesions
developing into diffuse ISR had less capacity to compensate for further plaque growth.
CONCLUSIONS Among the first ISR lesions, baseline positive remodeling was the most powerful predictor of
diffuse ISR. Measuring pre-interventional arterial remodeling patterns by IVUS may be
helpful to stratify lesions at higher risk. (J Am Coll Cardiol 2003;42:1731–8) © 2003 by the
American College of Cardiology Foundation
Although stents reduce the incidence of restenosis after
percutaneous coronary intervention (PCI) (1,2), in-stent
restenosis (ISR) still remains an unsolved problem. Angio-
graphic patterns of ISR are closely associated with prognosis
after repeated PCI. Compared with focal ISR (lesion 10
mm in length) in which repeated balloon angioplasty is
usually successful, diffuse ISR (lesion 10 mm in length) is
known to have a higher recurrent restenosis rate after
treatment with balloon angioplasty (3–6), as well as a higher
rate of target lesion revascularization after repeated PCI,
including balloon angioplasty, rotational atherectomy, exci-
mer laser coronary angioplasty, and stenting (7). Although
predictors of ISR have been reported frequently (8–10),
predictors of diffuse ISR have been reported less often.
Recently, the clinical, angiographic, and procedural predic-
tive factors of diffuse ISR among ISR lesions have been
reported (11,12), whereas parameters on intravascular ultra-
sound (IVUS) relating to diffuse ISR have not well been
characterized. In this retrospective study, we aimed to
determine the predictors of diffuse ISR among lesions
developing into ISR first by analyses of serial (pre-stent,
post-stent, and follow-up) IVUS studies. Moreover, subse-
quent vessel behavior after stenting in these ISR lesions was
evaluated by volumetric analyses of serial IVUS studies.
METHODS
Patient population. From January 1, 1998, through De-
cember 31, 2000, a total of 408 native coronary lesions in
305 consecutive patients were treated with stenting alone
and without debulking at the Cardiovascular Institute Hos-
pital in Tokyo. The patients were excluded if they had not
undergone follow-up angiography. There remained 341
lesions in 258 patients (85% [258/305]), of which 77 lesions
led to angiographic restenosis in less than one year (reste-
nosis rate 22.6%). The 77 ISR lesions were excluded when:
1) the stent diameter was 3.0 mm (n  7); 2) stent
implantation was performed without IVUS or with incom-
plete IVUS guidance (n  13; including 7 cases with
baseline chronic total occlusion); and 3) IVUS imaging
precluded accurate assessment because of intimal severe
calcification at the target lesion site or other technical
reasons (n  5). Finally, a total of 52 ISR lesions (68%
[52/77]) in 48 patients who had undergone successful
stenting alone with complete IVUS guidance was included
for analysis in this retrospective study. In these 52 ISR
lesions, recurrent ISR lesions were not included, although
14 lesions (27% [14/52]) developing into restenosis after
plain old balloon angioplasty were included.
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The kinds of stents used included tubular slotted stents
(Palmaz-Schatz [n  10], Multi-Link [n  14], NIR [n 
4], AVE GFX [n  2], Terumo [n  2], and BeStent [n 
8]) and coil stents (Wiktor [n  7], Gianturco-Roubin 2 [n
 3], and S670 [n 2]). There were 43 men and 5 women,
and their mean age was 65.5  8.1 years. These patients
underwent follow-up coronary angiography in three to nine
months (mean 4.9  1.7 months). Patient characteristics,
including risk factors for coronary artery disease, were
obtained from clinical records at the time of stenting.
Diabetes mellitus (only if treated medically), hypertension
(only if treated medically), and hyperlipidemia (only if
treated medically or if serum total cholesterol was 240
mg/dl) were all examined.
Angiography and analysis. Initial and follow-up angio-
grams were obtained in the same angiographic projections.
Two independent observers who were blinded to the results
of IVUS analysis performed quantitative coronary angiog-
raphy (QCA) analysis using computerized software (Car-
diovascular Measurement System, CMS, MEDIS, Leiden,
The Netherlands) with a contrast-filled catheter tip of a
known diameter as a scaling device. The reference diameter,
minimal lumen diameter, and diameter stenosis at end
diastole before intervention, after final balloon expansion of
the stent, and at follow-up were calculated on the computer
with the use of the view that showed the most severe
luminal narrowing. The mean reference artery diameter (or
reference diameter) was interpolated from the proximal and
distal reference segments. Lesion length was measured from
“shoulder to shoulder.” Short-term gain, late loss, loss index,
and net gain were calculated (13). Angiographic restenosis
was defined as 50% diameter stenosis at follow-up an-
giography. Diffuse ISR was defined as a follow-up lesion
length 10 mm and focal ISR as 10 mm.
Intravascular ultrasound imaging. A commercially avail-
able system (Cardiovascular Imaging Systems/Boston Sci-
entific, Natick, Massachusetts) was used for the IVUS
studies. The system consisted of a single-element, 30-MHz
transducer mounted on the tip of a flexible shaft and
rotating at 1,800 rpm within a 2.9F or 3.2F monorail
imaging catheter. The IVUS studies were also performed
before intervention, after final balloon expansion of the
stent, and at follow-up, although the follow-up IVUS data
could be acquired in only 31 (60%) of the 52 included
lesions. Intracoronary isosorbide dinitrate (5 mg) was in-
jected before image acquisition. After the IVUS catheter
was advanced at least 10 mm distal to the lesion, a
motorized auto pullback was performed at 0.5 mm/s to the
aorto-ostial junction. All IVUS images were recorded on
half-inch s-VHS videotape for off-line analysis.
IVUS analysis. Two experienced observers performed all
IVUS analyses. Quantitative analyses of IVUS images in the
end-diastolic phase were performed off-line using commer-
cially available planimetry software (CARDIO 500, Kon-
tron, Munich, Germany). Measured parameters consisted of
cross-sectional vessel area (VA), stent area (SA), and lumen
area (LA), which were manually traced. The VA was
defined as the area within the medial/adventitial border.
Plaque area (PA) was calculated as VA  LA, and percent
PA was calculated as: (PA/VA)  100 (%). Two-
dimensional analyses were performed at the tightest cross
section within the stent and at the sites of proximal and
distal reference segments, which were defined as the loca-
tion in the native vessel with the least amount of disease
within 5 mm from stent margins and before the emergence
of any major side branches. When the plaque encompassed
the IVUS catheter, the LA was assumed to be equal to the
size of the catheter. The ratio of change (delta) of each area
from post-stenting to follow-up was defined as: (area at
follow-up  area at post-stenting)/area at post-stenting 
100 (%). At follow-up IVUS studies, the neointimal area
within the stent was calculated as SA  LA.
The remodeling index (RI) before intervention was cal-
culated as the VA at the target lesion site divided by the
averaged VA of reference segments. Patterns of arterial
remodeling were classified into three categories: 1) positive
remodeling was defined as RI1.1; 2) intermediate remod-
eling as RI 0.9 to 1.1; and 3) negative remodeling as RI
0.9 (Fig. 1). Moreover, three-dimensional analysis was
performed by means of Simpson’s method. Vessel volume
(VV), stent volume (SV), and lumen volume (LV) were
computed for the entire stented segment. Plaque volume
(PV) was calculated as VV  LV, and percent PV was also
calculated as: PV/VV  100 (%). The neointimal volume
(NV) within the stent was calculated as SV  LV. The NV
and PV indexes were calculated as NV and PV divided by
stent length, respectively. The ratio of change (delta) of each
volume from post-stenting to follow-up was also defined as:
(volume at follow-up  volume at post-stenting)/volume at
post-stenting  100 (%).
Statistical analysis. Quantitative data are presented as the
mean  SD, and categorical data as frequencies (percent-
age). Continuous variables were compared using the un-
paired t test. Binary variables were compared by means of
the Fisher exact test, and the variables comprising more
than two categorical factors were compared by means of the
chi-square test. To identify the predictors of diffuse ISR,
multivariate logistic models were used. Univariate variables
Abbreviations and Acronyms
ISR  in-stent restenosis
IVUS  intravascular ultrasound
LV  lumen volume
PCI  percutaneous coronary intervention
PV  plaque volume
QCA  quantitative coronary angiography
RI  remodeling index
SV  stent volume
VA  vessel area
VV  vessel volume
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with p  0.20 were entered into the multivariate logistic
models. Statistical significance was defined as p  0.05. All
statistical analyses were performed with StatView version
5.0 (SAS Institute, Cary, North Carolina).
RESULTS
Patient, lesion, and procedural characteristics. Focal ISR
was present in 25 (48%) of 52 lesions analyzed in this study,
whereas diffuse ISR was present in 27 lesions (52%). As
shown in Table 1, no significant differences were seen in
clinical and lesion characteristics between the focal and
diffuse ISR groups. In Table 1, the variables such as “target
vessel” and “American College of Cardiology/American
Heart Association classification” were compared by the
chi-square test, and other categorical variables were com-
pared by the Fisher exact test. For the procedural charac-
teristics, there were trends toward a smaller stent to lesion
length ratio (1.3 0.9 vs. 1.7 0.9, p 0.11) and a smaller
balloon to artery ratio (1.2  0.2 vs. 1.4  0.3, p  0.11) in
the diffuse ISR group, which were not statistically signifi-
cant. The kinds of stents used were similar between the two
groups.
Angiographic results. Angiographic results are shown in
Table 2. Both baseline and post-procedural results were
similar between the two groups, except for a trend toward a
longer lesion length in the diffuse ISR group than in the
focal ISR group (17.1  8.6 m vs. 13.2  8.4 mm, p 
0.10). At follow-up, the diffuse ISR group had not only a
longer lesion length (16.3  4.9 m vs. 8.5  1.4 mm, p 
0.0001), but also a smaller minimal lumen diameter (1.0 
0.6 mm vs. 1.2  0.3 mm, p  0.07) and a larger diameter
stenosis (67.6  15.7% vs. 57.8  6.5%, p  0.01).
Consequently, the loss index in the diffuse ISR group was
larger than that in the focal ISR group (1.07 0.43 vs. 0.87
 0.25, p  0.04). Intra- and inter-observer variabilities on
QCA were 0.10 and 0.12 mm (r  0.973 and 0.956) for
minimal lumen diameter, respectively; 3.38% and 5.01% (r
 0.968 and 0.951) for percent diameter stenosis, respec-
tively; and 0.78 and 0.99 mm (r  0.966 and 0.949) for
lesion length, respectively.
Figure 1. Arterial remodeling patterns. The remodeling index (RI) before intervention was calculated as vessel area (VA) at the target lesion site divided
by the averaged VA of reference segments. Patterns of remodeling were classified into three categories: 1) positive remodeling was defined as RI 1.1; 2)
intermediate remodeling as RI 0.9 to 1.1; and 3) negative remodeling as RI 0.9. (A) Positive remodeling (RI  1.30). (B) Negative remodeling (RI 
0.65).
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IVUS results. Two-dimensional quantitative IVUS results
are shown in Table 3. The baseline minimal lumen area,
vessel and plaque area at the site of the minimal lumen area,
averaged reference lumen and vessel area, and minimal stent
area after stenting were all similar between the two groups.
However, baseline RI in the diffuse ISR group was signif-
icantly larger than that in the focal ISR group (1.03  0.18
vs. 0.88  0.24, p  0.02) (Fig. 2). In addition, negative
remodeling (RI 0.9) was seen in 60% of the focal ISR
group and, in contrast, in only 26% of the diffuse ISR group
(p  0.05 by the chi-square test) (Fig. 2).
Three-dimensional quantitative IVUS results are shown
in Table 4. Both the baseline and post-procedural volumes
of each component of the lesion were all similar between the
two groups. Among the 52 ISR lesions, follow-up IVUS
studies could be evaluated in 31 lesions comprising 16 focal
ISR and 15 diffuse ISR lesions. At follow-up, extra-stent
PV (calculated as VV  SV), PV, and the deltas of their
parameters were not significantly different between the two
groups. The NV index in the diffuse ISR group was
significantly larger than that in the focal ISR group (4.0 
1.5 mm3/mm vs. 3.0  1.1 mm3/mm, p  0.05). Con-
versely, delta-VV and delta-SV in the diffuse ISR group
were significantly smaller than those in the focal ISR group
(delta-VV: 0.5  12.2% vs. 5.7  9.9%, p  0.09;
delta-SV: 2.6  12.3% vs. 14.0  15.0%, p  0.03).
Consequently, percent PV in the diffuse ISR group was
significantly larger than that in the focal ISR group (76.8 
7.2% vs. 67.3  5.9%, p  0.01). Furthermore, among the
31 ISR lesions that had follow-up IVUS studies, the
baseline RI had a significant negative correlation with
delta-SV (r  0.377, p  0.04) and mildly with delta-VV
Table 1. Patient, Lesion, and Procedural Characteristics
Focal ISR
Group
(n  25)
Diffuse ISR
Group
(n  27) p Value
Age (yrs) 65  9 66  7 0.6739
Gender (M/F) 21/4 25/2 0.4109
BMI (kg/m2) 23.9  2.3 24.3  2.6 0.5878
Diabetes mellitus 7 (28%) 7 (26%)  0.9999
Hypertension 17 (68%) 16 (59%) 0.5737
Hyperlipidemia 11 (44%) 10 (37%) 0.7780
Smoking 19 (76%) 23 (85%) 0.4922
Previous MI 10 (40%) 10 (37%)  0.9999
ACS 4 (16%) 6 (22%) 0.7289
Restenotic lesion 6 (24%) 8 (30%) 0.7587
Multivessel disease 14 (56%) 14 (52%) 0.8691
Target vessel 0.6949
LAD 15 (60%) 19 (70%)
LCX 3 (12%) 3 (11%)
RCA 7 (28%) 5 (19%)
ACC/AHA classification 0.6559
B1 5 (20%) 3 (11%)
B2 14 (56%) 16 (59%)
C 6 (24%) 8 (30%)
Ostial location 2 (8%) 2 (7%)  0.9999
Bifurcation lesion 3 (12%) 3 (11%)  0.9999
Fluoroscopic calcium 11 (44%) 17 (63%) 0.2655
Number of stents (1/2) 22/3 20/7 0.2957
Type of stent (coil/tube) 5/20 7/20 0.7460
Stent diameter (mm) 3.3  0.4 3.4  0.4 0.5275
Stent length (mm) 18.1  6.9 18.3  5.5 0.8838
Stent/lesion length ratio 1.7  0.9 1.3  0.9 0.1104
Final balloon size (mm) 3.6  0.6 3.5  0.4 0.5149
Balloon/artery ratio 1.4  0.3 1.2  0.2 0.1089
Maximum pressure (atm) 13.6  3.2 14.3  3.4 0.4066
Data are presented as the mean value  SD or number (%) of patients.
ACC/AHA  American College of Cardiology/American Heart Association;
ACS  acute coronary syndrome; BMI  body mass index; ISR  in-stent
restenosis; LAD  left anterior descending coronary artery; LCX  left circumflex
coronary artery; MI  myocardial infarction; RCA  right coronary artery.
Table 2. Results of Quantitative Coronary Angiography
Focal ISR Group
(n  25)
Diffuse ISR Group
(n  27) p Value
Before intervention
Minimal lumen diameter (mm) 0.9  0.3 1.0  0.5 0.8745
Diameter stenosis (%) 64.5  12.0 66.9  14.5 0.5141
Reference diameter (mm) 2.8  0.6 2.9  0.6 0.2970
Lesion length (mm) 13.2  8.4 17.1  8.6 0.1042
After intervention
Minimal lumen diameter (mm) 2.8  0.5 2.8  0.7 0.8225
Diameter stenosis (%) 8.9  12.8 11.2  14.7 0.5434
Short-term gain 1.8  0.5 1.9  0.6 0.8998
Follow-up
Minimal lumen diameter (mm) 1.2  0.3 1.0  0.6 0.0739
Diameter stenosis (%) 57.8  6.5 67.6  15.7 0.0057
Reference diameter (mm) 2.8  0.6 2.8  0.7 0.9222
Lesion length (mm) 8.5  1.4 16.3  4.9 0.0001
Late loss (mm) 1.6  0.6 1.9  0.7 0.1640
Net gain (mm) 0.2  0.5 0  0.7 0.1384
Loss index 0.87  0.25 1.07  0.43 0.0438
Data are presented as the mean value  SD.
ISR  in-stent restenosis.
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Table 3. Two-Dimensional Quantitative Intravascular Ultrasound Results
Focal ISR Group
(n  25)
Diffuse ISR Group
(n  27) p Value
Before intervention
VA (mm2) 13.0  3.8 14.5  5.3 0.2481
LA (MLA) (mm2) 1.9  0.9 1.9  1.0 0.8705
PA (mm2) 11.1  3.6 12.6  4.8 0.2248
Percent PA 85.0  6.8 86.7  5.5 0.3630
Reference VA (mm2) 15.2  4.4 14.3  4.8 0.4497
Reference LA (mm2) 7.6  3.0 7.2  2.8 0.6505
Remodeling index 0.88  0.24 1.03  0.18 0.0159
Remodeling pattern (NR/IR/PR) 15/6/4 7/12/8 0.0456
After intervention
Minimal stent area (mm2) 6.1  1.9 6.3  2.1 0.6353
Maximal residual PA (mm2) 9.0  2.9 8.7  2.8 0.7493
Follow-up (focal: n  16; diffuse: n  15)
VA (mm2) 16.7  4.5 16.8  4.0 0.9458
Delta-VA (%) 11.1  18.4 5.7  14.4 0.3753
LA (MLA) (mm2) 2.3  1.1 2.2  1.3 0.8775
Delta-LA (%) 29.1  26.2 33.7  44.3 0.7251
Stent area (mm2) 7.5  2.1 7.5  2.2 0.9908
Neointimal area (mm2) 5.3  1.8 5.3  2.1 0.9352
PA (mm2) 14.4  4.0 14.6  3.7 0.9031
Delta-PA (%) 43.3  49.3 43.1  36.7 0.9896
Percent PA 86.3  5.3 86.8  7.1 0.8329
Data are presented as the mean value  SD.
Delta  ratio of change; IR  intermediate remodeling; ISR  in-stent restenosis; LA  lumen area; MLA  minimal
lumen area; NR  negative remodeling; PA  plaque area; PR  positive remodeling; VA  vessel area.
Figure 2. (A) Negative remodeling (remodeling index [RI] 0.9) was seen in 60% of the focal in-stent restenosis (ISR) lesions and, in contrast, in only
26% of the diffuse ISR lesions. Conversely, positive remodeling (RI 1.1) was seen in only 16% of the focal ISR lesions and in 30% of the diffuse ISR
lesions (p  0.0456 by the chi-square test). (B) The baseline RI in the diffuse ISR group was significantly larger than that in the focal ISR group
(1.03  0.18 vs. 0.88  0.24, p  0.0159). IR  intermediate remodeling; NR  negative remodeling; PR  positive remodeling.
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(r  0.268, p  0.09), whereas it did not correlate with
either delta-LV or delta-PV.
Finally, intra- and inter-observer variabilities on IVUS
were 0.28 and 0.46 mm2 for minimal lumen area (r 0.977
and 0.969), respectively; 5.71 and 7.72 mm3 (r  0.982 and
0.975) for vessel volume, respectively; and 2.68 and 4.93
mm3 (r  0.983 and 0.968) for lumen volume, respectively.
These results of variabilities on QCA and IVUS are
comparable to the previous reports.
Multivariate analysis. In this retrospective study, univari-
ate predictors of diffuse ISR with p value 0.20 were as
follows: higher baseline RI (p  0.02), longer baseline
lesion length (p  0.10), smaller stent to lesion length ratio
(p  0.11), and smaller balloon to artery ratio (p  0.11).
Multivariate logistic regression analysis revealed that the RI
was the only independent predictor of diffuse ISR (odds
ratio per 0.10 increment of RI: 1.46 [95% confidential
interval 1.03 to 2.08], p  0.0341).
DISCUSSION
This study demonstrated that the presence of the arterial
positive remodeling before stenting was associated with a
worse clinical outcome, such as diffuse ISR, after IVUS-
guided stent implantation. In addition, volumetric IVUS
analyses revealed that lesions developing into diffuse ISR
had not only more development of neointimal hyperplasia
but also less capacity of compensatory enlargement for
further plaque growth than did those developing into focal
ISR.
Predictors of diffuse ISR. Previous studies have shown
that the lesions with diffuse ISR had a high rate of recurrent
restenosis, which was a two- to threefold higher rate than
that of focal ISR lesions. Therefore, target lesion revascu-
larization for diffuse ISR lesions was much more frequently
required (3–7). In addition, thus far, no devices have
significantly improved clinical outcomes after the treatment
of diffuse ISR, except for intracoronary radiation therapy
(14). Moreover, as shown in the previous report (7) and this
study, diffuse ISR lesions were not only longer but also
tighter than focal ISR lesions, suggesting that diffuse ISR
represented biologically more active disease. On this basis,
early triage of lesions expected to develop into diffuse ISR
before the initial intervention is clinically important.
Goldberg et al. (12) revealed the following characteristics
as strongly predictive factors of diffuse ISR among ISR
lesions: 1) a longer baseline lesion length; 2) a smaller final
minimal lumen diameter after intervention; and 3) the use
of coil stents. These were all generally considered as
important predictors of usual ISR, too (8–10). In the
present study, although there was a trend toward a longer
lesion length in the diffuse ISR group, there were no
significant differences between the two groups as to the final
minimal lumen diameter and minimal stent area after
intervention, which was indicated as a powerful predictor of
Table 4. Three-Dimensional Quantitative Intravascular Ultrasound Results
Focal ISR Group
(n  25)
Diffuse ISR Group
(n  27) p Value
Before intervention
VV (mm3) 276.7  172.5 275.5  166.3 0.9786
LV (mm3) 91.0  60.9 83.0  56.7 0.6271
PV (mm3) 185.7  120.8 192.4  120.8 0.8422
Percent PV (%) 66.7  9.4 69.6  8.3 0.2409
After intervention
VV (mm3) 323.7  199.3 322.7  177.5 0.9846
LV ( SV) (mm3) 151.5  99.7 146.9  80.2 0.8526
PV (mm3) 172.1  103.2 175.8  102.9 0.8989
Percent PV (%) 53.7  6.7 54.3  6.5 0.7668
Follow-up (focal, n  16; diffuse, n  15)
VV (mm3) 344.6  208.4 292.6  92.0 0.3814
Delta-VV (%) 5.7  9.9 0.5  12.2 0.0928
SV (mm3) 174.5  114.8 141.3  48.6 0.3081
Delta-SV (%) 14.0  15.0 2.6  12.3 0.0284
LV (mm3) 116.6  82.4 68.2  38.6 0.0470
Delta-LV (%) 26.2  13.2 51.1  15.1 0.0001
NV (mm3) 57.9  37.2 73.1  32.2 0.2342
NV index (mm3/mm) 3.0  1.1 4.0  1.5 0.0362
PPV (mm3) 170.1  96.6 151.3  52.0 0.5099
Delta-EPV (%) 0.5  12.8 2.6  16.9 0.6997
PV (mm3) 228.0  129.6 224.4  68.1 0.9250
PV index (mm3/mm) 11.3  2.9 12.2  2.9 0.4076
Delta-PV (%) 35.4  15.9 46.0  28.1 0.2017
Percent PV (%) 67.3  5.9 76.8  7.2 0.0004
Data are presented as the mean value  SD.
Delta  ratio of change; ISR  in-stent restenosis; LV  lumen volume; NV  neointimal volume; EPV  extra-stent
plaque volume; PV  plaque volume; SV  stent volume; VV  vessel volume.
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both ISR and target lesion revascularization after stenting
(15,16). The reason for the discrepancy between Goldberg’s
study (12) and our study is unclear, but it may possibly relate
to the difference in the end point in interventional strategies
(e.g., aggressive stent implantation techniques using over-
sized balloons and/or high-pressure inflations) and the
number and characteristics of patients studied. Instead, this
study demonstrated that the baseline RI on IVUS was the
only independent predictor of diffuse ISR, showing that
positive remodeled lesions tended to develop into diffuse
ISR after stenting among the lesions developing into ISR.
Positive remodeling and clinical presentation. Recent
studies have shown that arterial remodeling as the response
to plaque growth, which was initially studied by Glagov et
al. (17), would play an important role in the complex process
of atherosclerosis from compensatory enlargement to plaque
disruption. There is evidence that positive remodeling may
be initially advantageous in that it prevents luminal stenosis
but disadvantageous in that significant expansive remodel-
ing may make the plaque more vulnerable (18,19). Inversely,
lesions with negative remodeling may be related to higher
grade stenoses (20,21), but may appear more stable.
Schoenhagen et al. (18) revealed that larger plaque and
vessel areas and positive remodeling were associated with
unstable angina pectoris, whereas negative remodeling was
more common in patients with stable angina pectoris. In
addition, other investigators suggested that in native coro-
nary lesions, pre-interventional arterial remodeling (positive
remodeling) was an independent predictor of target lesion
revascularization after a nonstent coronary intervention (22)
and also after stenting (23). Especially in the latter study, RI
was indicated as a more powerful predictor of target lesion
revascularization compared with the minimal stent area after
intervention, as indicated in the current study.
The mechanism by which coronary lesions showing
positive remodeling are associated with a worse clinical
outcome after intervention is still uncertain; however, it may
be partly related to the properties of lesions showing positive
remodeling, which might promote the development of
neointimal hyperplasia after stenting (24) and have less
capacity of compensatory enlargement for further plaque
growth after balloon angioplasty (25), as indicated in the
current study. Although the lesions in this study were all the
lesions developing into the first ISR, and most of them
(81%) were accompanied with stable angina pectoris, the
baseline RI was shown as the predictor of diffuse ISR,
suggesting that arterial positive remodeling was potentially
associated with biologically more active disease, even among
this study population.
Volumetric IVUS analyses demonstrated that delta-VV
and delta-SV in the diffuse ISR group were significantly
smaller than those in the focal ISR group, indicating that
lesions developing into diffuse ISR had less capacity to
compensate and enlarge for further plaque growth. Further-
more, there was a significant negative correlation between
baseline RI and delta-SV, and mildly between baseline RI
and delta-VV, supporting the hypothesis that lesions with
positive remodeling also had less capacity to compensate for
further plaque growth. These results were consistent with
the two-dimensional IVUS results after balloon angioplasty
in the previous report (25).
Positive remodeling and pathohistologic background.
Recent evidence from pathohistologic observations supports
the concept that positive remodeling is one of the charac-
teristic features of vulnerable plaques. In autopsy species of
human coronary arteries, pathohistologic studies have
shown that lesions with positive remodeling, compared with
lesions with vessel shrinkage, had a larger lipid core and a
higher macrophage count (26,27), which were recognized as
histologic markers for plaque vulnerability (28). Moreover,
other studies suggested that macrophages promoted expan-
sive arterial remodeling through increased matrix degrada-
tion by matrix metalloproteinases, especially 2 and 9
(29,30). These pathohistologic and biochemical investiga-
tions currently recognized may, in part, explain the complex
process of atherosclerosis and the clinical presentation of
coronary lesions with positive remodeling.
Study limitations. This analysis is retrospective and is
therefore subject to limitations inherent in this type of
clinical investigation. The results of this study should be
verified by further prospective investigation. Secondly, be-
cause the current study was subject to complete IVUS
analyses before and after intervention, lesions with baseline
chronic total occlusion, in which the IVUS study before
intervention tended to be impossible or incomplete, were
excluded from the present study. Therefore, the results of
this report could not be applied to lesions with baseline
chronic total occlusion, which was shown as having an
association with negative remodeling (27). Thirdly, the
lesions, which had undergone debulking by directional or
rotational atherectomy before stenting, based on each op-
erator’s decision, because stenting alone had been consid-
ered impossible to acquire the optimal luminal results, were
also excluded. This exclusion may also bias the results.
Fourthly, the sample size of this study was relatively small.
This may partly explain the small discrepancy between the
present study and the previous studies about the predictive
factors of diffuse ISR. Finally, we did not compare lesions
with ISR with lesions without ISR in this study. However,
many previous reports revealed that pre-interventional ar-
terial remodeling (positive remodeling) was a powerful
predictor of ISR or target lesion revascularization after
stenting (23,24), and the ultimate aim of this study was to
clarify the differences between focal and diffuse ISR lesions.
Conclusions. This study demonstrated that the baseline
RI (positive remodeling) on IVUS was a powerful predictor
of diffuse ISR among lesions developing into the first ISR.
Measuring arterial remodeling patterns before intervention
by IVUS may be helpful to stratify lesions at higher risk of
diffuse ISR.
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